QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
DGX$258.44-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Net income | $921 | $908 | $1,015 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustment | (76) | 5 | (8) |
| Net deferred gains on cash flow hedges, net of taxes | 2 | 2 | 1 |
| Other comprehensive (loss) income | (74) | 7 | (7) |
| Comprehensive income | 847 | 915 | 1,008 |
| Less: Comprehensive income attributable to noncontrolling interests | 50 | 54 | 69 |
| Comprehensive income attributable to Quest Diagnostics | $797 | $861 | $939 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.